Hyperscale Data (GPUS) announced the sale of its minority equity interest in a privately held pharmaceutical company for gross proceeds of $4.65M in cash. Hyperscale Data purchased the equity position for $1.5M in several closings between three and four years ago. This transaction is consistent with the company’s ongoing strategy to exit non-core investments and concentrate capital and resources on its primary asset-a 617,000 square foot data center located in Michigan, which is being developed to support high-performance computing workloads, including artificial intelligence applications.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GPUS:
- Hyperscale Data unit to launch XRP lending platform
- Hyperscale Data’s Ault Capital Group to purchase up to $10M of XRP
- Hyperscale Data says $TRUMP meme coin to be accepted payment on Bitnile.com
- Hyperscale Data reaffirms FY25 revenue view $115M-$125M
- Hyperscale Data Announces Cash Dividends for Preferred Stock